PROCYTE
LIVE

Serial Number

99020991

Owner

Flagship Labs 68, Inc.

Attorney

Christina M. Licursi

Filing Date

Jan 28, 2025

Add to watchlist:

No watchlists yet
View on USPTO

PROCYTE Trademark

Serial Number: 99020991

PROCYTE is a trademark filed by Flagship Labs 68, Inc. on January 28, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Flagship Labs 68, Inc. (3 trademarks)

55 Cambridge Parkway
Cambridge, MA 02142

Entity Type: 03

Trademark Details

Filing Date

January 28, 2025

Registration Date

Not Registered

Published for Opposition

November 11, 2025

Goods & Services

Bio-engineered cells for medical use; preparations of cells, namely, induced pluripotent stem cells (iPSCs), hepatocytes, induced pluripotent stem cell (iPSC)-derived hepatocytes, hepatocyte-like cells, adipose cells, and adipogenic cells in the field of cellular medicine for the treatment of genetic diseases and disorders, genomic diseases and disorders, metabolic disorders, orthopedic conditions, musculoskeletal diseases and disorders, gastrointestinal diseases and disorders, immune system-related diseases and disorders, dermatological diseases and disorders, cardiovascular diseases and disorders, neurological diseases and disorders, cancer, diabetes, and respiratory diseases and disorders; pharmaceutical and therapeutic preparations for the treatment of diseases, namely, genetic diseases and disorders, genomic diseases and disorders, metabolic disorders, orthopedic conditions, musculoskeletal diseases and disorders, gastrointestinal diseases and disorders, immune system-related diseases and disorders, dermatological diseases and disorders, cardiovascular diseases and disorders, neurological diseases and disorders, cancer, diabetes, and respiratory diseases and disorders; implantable therapeutics, namely, DNA vectors being molecules for delivering genetic material into cells and cells used for human gene therapy for medical use

Scientific research, pharmaceutical research, medical research; stem cell research services; technical scientific consultation and product development for others in the field of biotechnology, bioengineering, and the development of pharmaceuticals; pharmaceutical drug development services

Stem cells for research or scientific purposes

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 6, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 11, 2025 NPUB
PUBLISHED FOR OPPOSITION
Nov 11, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 5, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 10, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 6, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 6, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 6, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 15, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jul 15, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jul 15, 2025 CNRT
ASSIGNED TO EXAMINER
Jul 9, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 30, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Jan 28, 2025 MAFR
NEW APPLICATION ENTERED
Jan 28, 2025 NWAP